Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
about
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldSirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular EffectsGenetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysisExploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor.Influence of CHIEF pathway genes on gene expression: a pathway approach to functionalityCaffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathwaysGenetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese populationA pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer.Associations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations.Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis.mLST8 Promotes mTOR-Mediated Tumor Progression.Genetic association between PIK3CA gene and oral squamous cell carcinoma: a case control study conducted in Chongqing, ChinaTERT's role in colorectal carcinogenesis.Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacyDiet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach.Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma riskAssociation of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma.An integrated approach to identify causal network modules of complex diseases with application to colorectal cancerGenetic variants in the mTOR pathway and breast cancer risk in African American women.Innate immunity gene polymorphisms and the risk of colorectal neoplasiaPolymorphisms in the AKT1 and AKT2 genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population.Rosiglitazone regulates anti-inflammation and growth inhibition via PTEN.Gene-gene interactions in gastrointestinal cancer susceptibility.Targeting mTOR network in colorectal cancer therapyGenetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling.Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer.New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs.Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of metformin in phosphatase and tensin homolog-deficient RAW264.7 cells.Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population.Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population.The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer.The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphisms and lifestyle habits with colorectal cancer risk in a Chinese population.Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer.Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosisTargeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes
P2860
Q24620628-4D6AA528-D376-408C-9420-179CE4AB794CQ26749011-DD9D3E7B-B1C9-4166-A3F3-DD1231CFED70Q29248629-69736E17-0257-454C-9B0F-14877A60D1EEQ33762734-06611757-A5A5-42DF-B5CE-7AE221A41988Q33785564-7BF70E3F-44A8-44EF-BF43-D060C8CEF5E4Q33800268-D707D7BB-8DFB-4DD9-9050-D59F2791AE9AQ34345248-9ED9E2FA-CEBC-4900-A1F9-6352AA9265BFQ34653205-90CEE27D-2918-4A53-9E4E-0BB87171BCABQ34917952-070C9B55-8551-4C6F-BE51-71CFE430C709Q35053048-38C10A4B-5454-41DA-A74D-76C9E214035EQ35166585-4347C1AA-2B57-4840-8929-07907F4F73B3Q35612865-332D070D-932B-48C6-AA3C-7F1F7ABF4B09Q35883001-C5785EB0-33B7-451F-8228-7143EA2805FAQ36185880-90C086E0-921A-499C-AA48-6DCB41665403Q36302221-6D85E58B-914D-48A1-BC29-41BDED62EC12Q36353357-FF0A6667-5E18-4F97-956B-AF1C6C4DC24BQ36582330-4949B99A-D970-4DF8-BE61-05909E952D83Q36656385-19EB89AE-D65A-42E8-BD64-FBE15EBA62F7Q36697770-10C86303-4AF9-401D-9F92-C621FE773B49Q36780387-50908F23-C886-40B5-B532-C4A973D45B43Q37039848-C4EC50F3-2758-4B44-B56D-D297DABC2CCAQ37220236-02A7AE35-BB09-40BB-A53C-7E36D13A30DDQ37262162-A8EC0622-D63B-4DEA-9312-AB3035AEA5F5Q37447740-CA771E7A-4FF6-4FC7-8E01-EEC79962AAF0Q37677252-7E82F5A5-9C7E-4D82-B93D-864A15862956Q37687212-D24A0737-E6C1-4B5C-8498-DABA1D573271Q37708005-C8E4DB91-2B9D-4B74-B632-0E35427B44FFQ37725516-1ED7DF5B-8654-48D7-AA1E-98AE5ACD5B61Q38017247-2CC0C27C-5AEC-4749-A540-39C382432428Q38329296-F90DEF5C-21EF-46F1-B873-C5A14E176885Q38707932-6F7EF491-4562-4476-9E46-39F824989B87Q39093766-84D46A21-51DD-4928-82A5-CC852F4E1144Q42128311-92D22D5C-38DF-4D44-942B-EB23CF85AAA1Q44435172-35991E69-2521-400A-9B4F-277B693FCC6CQ45254443-BDA80741-A87B-4CF3-9CDA-59EF272A973CQ46201739-B46DF191-4CB8-4811-8BC0-6F194ECFD383Q53235759-30F01C79-49A3-46A7-8952-D87791ACFBFEQ53284467-AC5926C2-58BF-4042-A732-7EEB21129040Q58763368-0D1528AC-880A-4871-BADA-A04F47FDBD98Q58778156-2E45F82C-5A93-4265-B376-7637EBDFEDCC
P2860
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@ast
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@en
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@nl
type
label
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@ast
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@en
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@nl
prefLabel
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@ast
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@en
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@nl
P2093
P2860
P356
P1433
P1476
Genetic variation in a metabol ...... G2, TSC1, TSC2, PI3K and Akt1.
@en
P2093
Abbie Lundgreen
Francis A Fitzpatrick
Karen Curtin
Roger K Wolff
P2860
P304
P356
10.1093/CARCIN/BGQ142
P407
P577
2010-07-09T00:00:00Z